ANI Pharmaceuticals
Price & Volume
Stats
See moreOpen | $89.51 |
Previous Close | $88.54 |
Day Range | $87.48-$89.65 |
52W Range | $52.50-$99.50 |
Market Cap | $1.9B |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $826.8M |
Revenue Growth (YoY) | 53.6% |
Gross Profit (12 Mos) | $502.3M |
Diluted EPS | $1.60 |
News
See moreYahoo Finance • 5 days ago
ANI Pharmaceuticals Reports Record Third Quarter 2025 Financial Results and Raises 2025 Guidance
Yahoo Finance • 19 days ago
ANI Pharmaceuticals to Discuss Third Quarter 2025 Financial Results on November 7, 2025, at 8:30 a.m. ET
Yahoo Finance • 27 days ago
ANI Pharmaceuticals Announces NEW DAY Clinical Trial Results to be Presented in Late-Breaking Oral Presentation at the American Academy of Ophthalmology 2025 Meeting
Yahoo Finance • 2 months ago
Carlyle Group Reaches Analyst Target Price
About
CEO | Mr. Nikhil Lalwani |
CFO | Mr. Stephen P. Carey |
Address | 210 Main Street West, Baudette, MN, United States, 56623 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 897 |
